SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
Nan Yang, Lisa Hoeg, Xuechun Bai, Sizhi Gao, Elisa de Stanchina, David B. Solit, Sabine Topka, Sami Belhadj, Jian Carrot‐Zhang, Gopa Iyer, Daniel Durocher, Kent William Mouw, Joseph Vijai, Kenneth Offit, Steven M. Lipkin
This study identifies SLC25A28 as a synthetic lethal target in NER-deficient cancers, showing its loss impairs cell viability and increases oxidative stress.
bioRxiv · Oct 6, 2026 · PreprintCancer Biology